Home › Schizophrenia › North Carolina
Schizophrenia clinical trials in North Carolina
4 studies for Schizophrenia are looking for participants at sites in North Carolina.
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Vanda Investigational Site, Kinston
RecruitingPhase 4
Ages 12 to 17 · All sexes · Updated Oct 1, 2026 · NCT05648591Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- New Dawn Psychiatric Services, PLLC, Kinston
- New Dimension Group, Rose Hill
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07101094Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Magnolia Clinical Research, LLC, Cary
- PPD Virtual - PPD - US, Wilmington
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT07379827Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
- University of North Carolina at Chapel Hill, Chapel Hill
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated May 4, 2026 · NCT05208190From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.